H.L. Hall & Sons Limited – Trademark Portfolio
Entity Type: 11
H.L. Hall & Sons Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ZEMBRIN. The owner is based in Mpumalanga.
Farm Mataffin, # 305, Reg. Section JT
District NELSPRUIT
Mpumalanga , ZA
Showing of trademarks Trademarks
Trademark Classifications
H.L. Hall & Sons Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does H.L. Hall & Sons Limited have?
H.L. Hall & Sons Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does H.L. Hall & Sons Limited file in?
H.L. Hall & Sons Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are H.L. Hall & Sons Limited's most well-known trademarks?
H.L. Hall & Sons Limited's registered trademark portfolio includes well-known marks such as ZEMBRIN. These are among 1 currently registered trademark in the portfolio.
What is H.L. Hall & Sons Limited's trademark registration success rate?
H.L. Hall & Sons Limited has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.